📰 Psycheceutical Bioscience News
Psycheceutical Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Psycheceutical Bioscience. Real-time updates on events, politics, business and more.
January 17, 2024
The distress in the psychedelic space contributed to the Company's challenges.The inability of the Company to undertake certain corporate actions (name and symbol change etc.) due to regulatory filing deficiencies from over a decade ago has hampered the ability of the Company to reposition itself.MIAMI, FL / ACCESSW...
November 6, 2023
Shark Tank’s Kevin Harrington thinks safe psychedelic medicines without the “trip” are the future of mental health care, and has put his support behind Psycheceutical - Click Here To Invest
October 6, 2023
Ketamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.
September 26, 2023
Psychedelics have re-emerged in the world of medicine as promising treatments for various mental health conditions, particularly post-traumatic stress disorder (PTSD).
September 3, 2023
Psycheceutical Bioscience, Inc (OTCPK: BWVI) is a cutting-edge biotech startup that developed a topical drug delivery system called NeuroDirect, a system that can be used to deliver psychedelic drugs directly to the brain, avoiding the traditional “high” and side effects.
September 3, 2023
Psycheceutical Bioscience, Inc BWVI is a cutting-edge biotech startup that developed a topical drug delivery system called NeuroDirect, a system that can be…
August 10, 2023
Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose ...
August 1, 2023
Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future ...
April 13, 2023
As Psycheceutical prepares to begin clinical trials for its novel NeuroDirect™ ketamine topical to treat PTSD, the company is named to Life Science Reviews yearly Top Biotech Start-Up... | April 13, 2023